Indians develop new oral cholera vaccine
Indian scientists have finally come up with an oral vaccine for cholera.This oral recombinant cholera vaccine is the fruit of two years of research by three scientists - Dr Amit Ghosh of the Institute of Microbial Technology, Chandigarh, Dr G.B. Nair of the National Institute of Cholera and Enteric Diseases, …
- Sanctions may affect Orissa health project
The absence of communication from the Centre on sanctions imposed by Japan, USA and other countries as well as its implicaitons on international financial institutions etc has left the state government confused over its ramifications as far as Orissa is concerned. Projects for which agreements have already heen signed will …
- Nephrological society threatens to stop dialysis
Agitated over the "misbehavioyr" of the lawyers and the police in the kidney transplant case, the Delhi Nephrological Society, under the auspices of the Delhi Medical Association, has threatened to stop all dialysis activities in the Capital from Monday.
- WHO slashes aid
A proposal approved by the WHO Executive Board has envisaged a cut in allocation of funds to India by $5 million. It would now be less than $10 million.
First satellite clinic at Apollo
Delhi Chief Minister Sahib Singh Verma on Saturday inaugurated the first satellite clinic of Indraprastha Apollo Hospital here.
Health Trust Fund launched
The Bhutan Health Trust Fund was launched in Geneva by the Deputy Prime minister for Health and Education, coinciding with the 51st session of the World Health Assembly.
PFC to finance two hydel projects in UP
The Power Finance Corporation has agreed to invest Rs 600 crores in UP to kick start the state's two long pending hydel power projects, Maneri Bhali and Lakhwar Vyasi.
Ad council cracks the whip
With as much as Rs 276 crore coming in from the tobacco industry, advertising agencies in India are altering strategies to abide by a new code, what would ban commercials luring children into smoking cigarettes or chewing tobacco.
Take a heart ! Super aspirin is here
The US Food and Drug Administration (FDA) approved a 'super aspirin' to prevent blood clots. The new medicine, inspired by snake venom, could dramatically reduce the risk of heart attacks in people hospitalized with a dangerous type of severe chest pain.
Hepatitis 'B" thrives as HIV hogs limelight
Dubbed as a virus deadlier than the AIDS causing "HIV", Hepatitis B Virus (HBV) kills 2.5-lakh Indians every year, notwithstanding a simple vaccine that could keep fatal liver disorders away. Almost four per cent of our population harbour "HBV" in their blood which renders them highly vulnerable to liver cirrhosis …
Maharashtra facing acute water problem
Over 50 million people of Maharashtra living in villages and urban slum-dominated areas are facing unprecedented water-scarcity, and poor water-quality, according to economist and former member of the Maharashtra State Planning Board, Prof. H.M. Desarda. Lambasting the water policy of the Maharashtra Government, Prof. Desarda, who has just completed a …
Breast cancer drug said to benefit all ages
A drug for breast cancer, tamoxifen, significantly reduces the rates of recurrence and death from the disease among surprisingly wide range of women but is being prescribed to far too few patients, researchers have reported in the world's largest analysis of any cancer treatment.
Link to ailments under study
Swedish researchers said they had found an apparent link between using mobile telephones and fatigue, headaches and tingling and heat sensations in the ear and skin.
Putting the bite on the drill
The word is that the dentists drill could one day be a thing of the past thanks to a new vaccine that prevents tooth decay. The vaccine is spread on the teeth. The tests are being carried out at the Hospital Dental School in London. Trials have shown the vaccine …
Role reversal
A new report suggests that too much vitamin C can harm cells and may even cause heart disease and cancer. Joseph Lunec, a chemical pathologist at Britain's Leicester University, says his studies show that when taken in large quantities, vitamin C stops working as an anti-oxidant.
New weapons in cancer war
Medical researchers are tackling cancer in many different ways. The estimated 300 experimental cancer drugs range from orthodox chemotherapy to biotechnology approaches such as antibodies and gene therapy.
